首页> 外文期刊>BMC Complementary and Alternative Medicine >Antimalarial activity of Garcinia mangostana L rind and its synergistic effect with artemisinin in vitro
【24h】

Antimalarial activity of Garcinia mangostana L rind and its synergistic effect with artemisinin in vitro

机译:芒果藤的抗疟活性及其与青蒿素的体外协同作用

获取原文
       

摘要

Background Malaria especially falciparum malaria still causes high morbidity and mortality in tropical countries. Several factors have been linked to this situation and the most important one is the rapid spread of parasite resistance to the currently available antimalarials, including artemisinin. Artemisinin is the main component of the currently recommended antimalarial, artemisinin based combination therapy (ACT), and it is a free radical generating antimalarial. Garcinia mangostana L (mangosteen) rind contain a lot of xanthone compounds acting as an antioxidant and exhibited antimalarial activity. The aim of this study was to evaluate the antimalarial activity of mangosteen rind extract and its fractions and their interaction with artemisinin against the 3D7 clone of Plasmodium falciparum in vitro. Methods Dry ripe mangosteen rind was extracted with ethanol followed by fractionation with hexane, ethylacetate, buthanol, and water consecutively to get ethanol extract, hexane, athylacetate, buthanol, and water fractions. Each of these substances was diluted in DMSO and examined for antimalarial activity either singly or in combination with artemisinin in vitro against Plasmodium falciparum 3D7 clone. Synergism between these substances with artemisinin was evaluated according to certain formula to get the sum of fractional inhibitory concentration 50 (∑FIC50). Results Analysis of the parasite growth in vitro indicated that IC50 of these mangosteen rind extract, hexane, ethylacetate, buthanol, and water fraction ranged from 0.41 to?>?100?μg/mL. All of the ∑FIC50 were Conclusions This study demonstrated a promising antimalarial activity of the extract and fractions of G.mangostana L rind and its synergistic effect with artemisinin. Further study using lead compound(s) isolated from extract and fractions should be performed to identify more accurately their mechanism of antimalarial activities.
机译:背景技术疟疾,尤其是恶性疟疾,在热带国家仍然导致高发病率和高死亡率。几种因素与这种情况有关,最重要的因素是寄生虫对包括青蒿素在内的现有抗疟疾药物的耐药性迅速扩散。青蒿素是目前推荐的基于青蒿素的联合治疗(ACT)的主要抗疟药成分,它是一种产生自由基的抗疟药。藤黄果皮(山竹果皮)含有大量的黄酮类化合物,可作为抗氧化剂并具有抗疟疾活性。这项研究的目的是评估山竹果皮提取物及其级分的抗疟活性,以及​​它们与青蒿素在体外对恶性疟原虫的3D7克隆的相互作用。方法用乙醇提取成熟的山竹果皮,然后依次用己烷,乙酸乙酯,丁醇和水进行分馏,得到乙醇提取物,己烷,乙酸乙酯,丁醇和水的馏分。将这些物质中的每一种都在DMSO中稀释,然后单独或与青蒿素联用进行体外抗恶性疟原虫3D7克隆的抗疟药活性检测。根据一定的公式对这些物质与青蒿素的协同作用进行了评估,得出总抑菌浓度为50(∑FIC 50 )。结果体外寄生虫生长分析表明,山竹提取物,己烷,乙酸乙酯,丁醇和水的IC 50 范围为0.41至≥100μg/ mL。所有∑FIC50均为结论。本研究证明了山竹提取物及其部分的抗疟活性及其与青蒿素的协同作用。应使用从提取物和馏分中分离的铅化合物进行进一步研究,以更准确地确定其抗疟活性的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号